Monday, 29 May 2017

Global Streptococci Testing Market By Analysis of Major Industry Segments 2016 - 2024

Streptococci Testing Market: Overview

Streptococcal infections are caused by a microorganism called Streptococcus which is a non-motile, microaerophilic, grampositive spherical bacterium. Several disease causing strains of the bacteria include streptococci (groups A, B, C, D, and G). Each group causes specific types of infections and symptoms. Group A strain of the bacteria are the most virulent species for humans and cause wound and skin infections, strep throat, scarlet fever, tonsillitis, blood infections (septicemia), pneumonia, Sydenham's chorea., rheumatic fever and glomerulonephritis.

Streptococci are known to originate from several natural sources, including humans and diverse animals. These bacteria often colonize on the mucosal surfaces of the mouth, nasal passages, intestinal tract, and pharynx. Moreover, the bacteria may also cause contamination of drinking water due to feces. Food products which are at high risk of contamination include milk and dairy products, steamed lobster, eggs, potato salad, ground ham, rice pudding custard, and shrimp salad. Some streptococci are commercially important for the production of cheese and yogurt, though are known to be potent pathogen.


The bacteria species which do not cause any infection and are used in food industry include S. lactis, S. diacelillactis S. cremoris, and S. thermophilus, the latter being the most well-known. The factors affecting the incidences of sore throats (pharyngitis) include seasonal variation, patient’s age, and geography. Pharyngitis most of the times is bacterial, though can be viral. Children ranging from 5 to 15 years of age are most susceptible to the infection by group A strep during the winter or early spring season. Symptoms of this infection include stomach aches, headaches, vomiting, nausea, and listlessness.

Streptococci Testing Market: Key Segments

The global streptococci testing market can be segmented based in tests type, end users and geography. Antibody tests include the antistreptolysin O titer (ASO), anti-DNase-B (ADB) test and Streptozyme. ASO test helps in determining a kidney disease glomerulonephritis, scarlet fever or rheumatic fever. ADB test is performed to determine a previous infection of a group A beta-hemolytic Streptococcus. Streptozyme is a screening test used to detect antibodies to several streptococcal antigens. Diagnostic tests include throat culture and rapid antigen test. Diagnostic tests are used to confirm the infection where in the sample from the infected area is used as culture, a means of growing bacteria artificially in the laboratory.

The cause of a sore throat is usually diagnosed on the basis of a physical exam and lab tests. A throat culture also known as strep test helps in detection of the presence of group A strain of streptococcal bacteria by using a throat swab. This strain is the most common cause of strep throat infection. Various other infections caused by these bacteria include pneumonia, meningitis and tonsillitis. Rapid antigen test can detect strep bacteria in minutes by looking for substances (antigens) in the throat. The rapid strep test detects the presence of a carbohydrate antigen which is unique to group A Streptococcus.

The downside to the rapid test is that it cannot detect the presence of Group C and G which can also cause streptococcal pharyngitis. On positive rapid strep test, the treatment is started with appropriate antibiotics to prevent long-term damage and recurrence. End users segment include hospitals, private labs, physicians offices and public health labs. Geographically, the global streptococci testing market is segmented into four major regions namely, North America, Europe, Asia-Pacific and Rest of the World.

Streptococci Testing Market: Key Players

The key players contributing to Streptococci market include Abbott Diagnostics, Beckman Coulter, bioMerieux, DiaSorin, Hologic, Qiagen, Roche Diagnostics, Novartis Diagnostics, Ortho Clinical Diagnostics, Sigma Aldrich, and Thermo Fischer Scientific.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11516

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Global Medical Pendant Systems Market Analysis, Trends and Forecast by 2016 - 2024

The growing need for a safe and low-risk work space for the medical workforce is driving the global medical pendant systems market. Medical pendant systems help provide correct positioning of terminal units, medical equipment, medical gas, and specialty and electrical services, thus fulfilling the requirements of a hospital. Moreover, since electrical and gas services are facilitated from the ceiling, cable clutter is eliminated, making the place safer and cleaner for activities and movement of medical professionals. 
The global medical pendant systems market is segmented on the basis of type, application, and geography. On the basis of product the market is segmented into fixed, fixed retractable, double multi-arm, and single arm movable. By application, the global medical pendant systems market is segmented into surgery, anesthesia, endoscopy, and ICU.
The report offers a detailed overview of the market segments and sub-segments. The trends and opportunities in the market are discussed at length. A detailed analysis of factors driving and restricting the market has been included. The report presents an evaluation of the market by making use of historical data, current market status, and qualitative insights. The macro and microeconomic indicators have also been analyzed in the study.


Overview of the Medical Pendant Systems Market

The global medical pendant systems market is driven by the growing need for these systems in intensive care units and operating theaters. The adoption of medical pendant systems has been fueled by the effective results achieved in the areas of endoscopy and surgery. A growing demand for medical support systems with advanced features is another factor driving the market. Moreover, innovation and technological advancements enabling medical pendant systems to move as needed by the press of a button are encouraging the adoption of these systems. However, the market is restricted by the high cost of medical pendant systems, causing many hospitals to hesitate in adopting these systems. Hospitals unable to afford these systems contemplate using alternatives, which can be a threat to the growth of the market.

The rising demand for flexible, more space saving, and light-weight systems and systems with multiple features is compelling manufacturers to design and develop newer systems with advanced features. This is leading to many product innovations and will thus boost the demand for medical pendant systems. Another trend in the market is the development of medical pendant systems with higher number of electrical points and gas services. The high usage of electronic devices by hospitals is driving this trend. Such innovations in products are expected to open new doors of opportunities in the market.

The global medical pendant systems market is segmented on the basis of geography into Europe, Asia Pacific, North America, and the Rest of the World. Of these, North America led the market in 2015. The market in Asia Pacific is expected to grow considerably owing to higher investments in the healthcare sector. By type, the demand for fixed retractable medical pendants is expected to be high, as per TMR analysts.

Companies Mentioned in the Report

The report profiles major players operating in the global medical pendant systems market. The business and financial overviews of each of the companies have been included. Factors driving and limiting the growth of the companies are also included. The report includes strategies adopted by key players, their recent developments, and product picture and specifications. This enables readers and enterprises to make informed decisions regarding investments in the global medical pendant systems market. Following are the companies studied in the report: ELEKTRA HELLAS, Uttam,Starkstrom, Hipac, Unicorn Medicals, Ondal, Brandon Medical, Beacon Medaes, Medilon, and Medimax.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11696

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Global Restless Legs Syndrome Treatment Market By Analysis of Major Industry Segments 2016 - 2024

Global Restless Legs Syndrome Treatment Market: Overview

Restless legs syndrome, also called Willis-Ekbom disease, is a neurological disorder. It triggers an urge in patients to move their legs. Because the syndrome usually occurs during sleep, it is also considered a type of sleep disorder. People suffering from restless legs syndrome often feel an overwhelming desire to rigorously move their legs, the intensity and frequency of which leads to unpleasant pain in their limbs. This also disturbs their sleep patterns, affecting their health adversely. The condition usually aggravates at night. 

Higher prevalence of restless legs syndrome is noted in women than in men. RLS can affect people of all ages but is mostly observed in middle-aged and elderly people. The most common symptoms of RLS include uncomfortable itching and pain in the legs that may cause a disruption in the sleep pattern and ultimately affect a patient’s quality of life. Despite its increasing prevalence, the precise cause of RLS is not yet known. Nevertheless, with extensive investigations being conducted in the field, the RLS market is expected to gain momentum in the near future. As of now, experts attribute the increasing incidence of the disease to genetic factors and instabilities in the dopaminergic balance.


While researchers are yet to discover a specific cure for the disorder, drugs presently available in the market ensure symptomatic treatment. They help in relieving the uneasiness commonly experienced in the disorder. The report studies the prospects for the global restless legs syndrome treatment market in the forthcoming years. The impact of research and development activities on the market’s future outlook is examined in the report in detail. It also presents insights into the various social and economic factors that will influence the market’s growth trajectory between 2016 and 2024.

Global Restless Legs Syndrome Treatment Market: Opportunities and Market Segmentation 

Restless legs syndrome causes uneasiness in patients and is also associated with other health issues such as dizziness, headaches, drowsiness, flatulence, dry mouth, and nausea. Patients suffering from restless legs syndrome may also suffer from psychiatric disorders such as depression and a decreased libido. Apart from these, labyrinthitis and other ear disorders, fatigue, irritability, peripheral edema, and nutritional and metabolism disorders indicated by weight gain or increased appetite are also related to the syndrome.

The treatment of restless legs syndrome is still a relatively untapped space. The market is projected to exhibit growth at an increased rate with the development of new drugs, which promise higher efficiency and minimum side effects.

Based on product type, the global restless legs syndrome treatment market can be segmented into Neupro/Leganto, Mirapex/Sifrol/Mirapexin, HORIZANT/Regnite, and Requip. Restless legs syndrome treatment can be segmented into pharmacological and nonpharmacological.

Global Restless Legs Syndrome Treatment Market: Competitive Insights 

In order to study the competitive landscape prevailing in the market, the report profiles companies such as GlaxoSmithKline plc., Kyowa Hakko Kirin Co., Boehringer Ingelheim GmbH, Jazz Pharmaceuticals, Inc., and Manhattan Pharmaceuticals. The strengths and weaknesses of the companies are weighed out in the report using SWOT analysis. The analysis also helps the report gauge the threats and opportunities that these companies could face in the near future.

The report offers a complete databank about the global restless legs syndrome treatment market by providing in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information regarding every facet of the market.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12506

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Global Lithotripsy Device Market Share by Industry Research 2016 - 2024

Lithotripsy is the treatment used to cure stones or other calculus in kidney or other organ of body such as gall bladder or liver. Stones occur due to deposition of minerals and other substances in crystalline form. Stones appear in different forms such as tiny small stones, sharp-edged, large size stones. Stones are usually removed from the body through urination. Large size stones are not able to pass through routine urination. Lithotripsy is a procedure where sound waves are used to break large stones into tiny particles which can be easily excreted through urination. The shock waves used in lithotripsy are high energy shock waves. 


Lithotripsy is an outpatient treatment. High energy shock waves are generated which are allowed to pass through the body to the site where stone is present. These waves break the large stone into tiny small particles, which are easily removed from the body through normal urination process. It is a non-invasive procedure to get rid of stones with the help of acoustic pulse. It is used to treat stones of kidney, gall bladder, and liver, and have been reported to be used for treatment of salivary stones and pancreatic stones. Lithotripsy is a non-invasive procedure, which is preferred to surgery. A patient does not need to get hospitalized and is discharged on the same day and can attain his routine lifestyle from the next day. Non-invasive nature of the treatment makes it safe and helps in quick recovery as compared to invasive surgery procedures. Non-invasive procedure, safe, and rapid recovery are projected to drive the lithotripsy device market. Several risks are associated with lithotripsy treatment. This treatment is not considered for patients suffering from bleeding disorder and pregnant women. The results are much satisfactory in case of large stones than small stones. Sometimes the procedure results in internal bleeding and may need blood transfusion. It can lead to adverse side effects where kidney may be damaged due to blockage in flow of urine passage caused because of tiny stone particles. Complications such as high blood pressure and above factors restrain the market. 

The lithotripsy device market can be segmented based on technology, application, and region. In terms of technology, the market can be segmented into intracorporeal lithotripsy and extracorporeal lithotripsy. Intracorporeal lithotripsy can be sub-segmented, based on instruments used for generation of energy and breaking of stones, into mechanical lithotripsy, electrohydraulic lithotripsy (EHL), laser lithotripsy, and ultrasonic lithotripsy. EHL and laser lithotripsy require direct visualization, which becomes difficult technically. Intracorporeal lithotripsy is carried out with the help of ureterscopy in cases where extracorporeal lithotripsy is not possible due to its position, size, and density. Extracorporeal lithotripsy also termed as extracorporeal shock wave lithotripsy (ESWL) is carried outside the body where high energy shock waves are allowed to pass through the body. The energy generator is used to attain required intensity of shock wave which cleaves the large stone into tiny sand size particles. ESWL has rapidly replaced the surgery options due to its non-invasive nature, outpatient process, and quick recovery. 

Based on application, the lithotripsy device market can be segmented into kidney stone, pancreatic stones, bile duct stone (biliary lithotripsy). Lithotripsy seems to be safe and reliable treatment for bile duct stone and pancreatic stone. Rise in prevalence of kidney stone disorders and awareness about lithotripsy technology among urologists has estimated to cover the largest market in this segment. 

In terms of region, the lithotripsy device market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe is estimated to be the largest market for lithotripsy devices. Asia Pacific is anticipated to be the fastest growing market due to its new and advance technology development and awareness about these technology among the population and health care sector. 

Key players in the lithotripsy device market are Siemens Healthineers, Medtronics, Boston Scientific, DirexGroup, Ince Medical, ELMED Elektronik ve Medikal San. TIC. A.S., Grupo Maxwerk, Haiying Enterprises Group Co. Ltd., and Olympus Corporation. 

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19094

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Global Scaffold Technology Market Analysis, Trends and Forecast by 2016 - 2024

Scaffolds are artificial extracellular matrices that support 3D tissue regenerations and accommodate cells. These can be temporary or permanent matrices which provide chemical, mechanical, and biological support for tissue formation. Scaffold technology is employed to perform 3D culture assays that include cell to cell interactions, high throughput screening, cell to matrix interactions, transfections, and cell migration assays. Growing regenerative technology has been attributed to the growth of the scaffold technology market which has led to the development of bio-scaffolds. Scaffolds act as a template for tissue formation, which are subject to biophysical stimuli through a bioreactor, a system which applies chemical and mechanical stimuli to the cells; or are provided with growth factors. 

In terms of material, the scaffold technology market can be segmented into bio-inert, bioresorbable, and bioactive. Based on technology, the market can be segmented into nanofiber-based scaffolds, polymeric scaffolds, hydrogels, and micro-patterned surface microplates. In terms of application, the scaffold technology market can be segmented into drug development, tissue culture, cancer treatment, stem cell research, and regenerative technology. End-users in the scaffold technology market include biotechnology and pharmaceutical organizations, research laboratories, hospitals, and diagnostic laboratories. In terms of region, the market can be segmented into North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. 


Scaffold technology provides opportunities to address the challenges associated with tissue culture such as vascularization and enable organ implant regeneration employed in the treatment of damaged and diseased organs or tissues. Increasing number of applications would contribute to the growth of scaffold technology market. In addition, rising accidents leading to organ damage and increase in geriatric population that add to the rising number of people with non-functioning of organs contribute to the growth of the scaffold technology market. In addition, ongoing research on designing matrix-based 3D substrates that enable interaction between implants and host microenvironment for optimal functioning of the implanted cells and drug release is expected to boost the market in terms of revenue during the forecast period. However, the emergence of scaffold-free technology for cell culturing is expected to hamper the scaffold technology market during the forecast period. 

Hydrogels based scaffolds are expected to dominate the scaffold technology market due to the continuous progress in their development. However, nanofiber-based scaffolds are expected to record highest growth rate during the forecast period, owing to the growing nanotechnology and their ability to mimic nanoscale properties. Growing investments by biotechnology companies for the development of products related to scaffold technology is expected to contribute to the growth of the scaffold technology market. 

North America is expected to dominate the scaffold technology market. Growth of the market in the region can be attributed to well-developed infrastructure in the region, ongoing research, and the presence of major market players in the region. However, the scaffold technology market in Asia Pacific is expected to record the highest growth rate during the forecast period, owing to the increasing government focus on boosting research and development in the pharmaceutical industry and the improving health care infrastructure in the region. 

Leading players in the scaffold technology market include 3D Biomatrix, 3D Biotek LLC, Acelity (LifeCell Corporation), Avacta Life Sciences Limited, Becton, Dickinson and Company, Medtronic (Covidien plc), Merck KGaA (Sigma-Aldrich Co. LLC), Molecular Matrix, Inc., Molecular Partners, Nanofiber Solutions, NuVasive, Inc., Pelo Biotech GmbH, ReproCELL Europe Ltd. (Reinnervate), Thermo Fisher Scientific, Inc., Vericel Corporation, and Xanofi. The leading players in the market have been focusing on diversifying their product portfolios and expanding their distribution networks to strengthen their market position.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18695

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Friday, 26 May 2017

Global Surgical Stapling Devices Market Share by Industry Research 2016 - 2024

Global Surgical Stapling Devices Market: Overview

Surgical stapling devices were developed in response to rising concerns regarding the healing of traditional sutures. Compared to modern surgical staplers, sutures are more prone to separation and leaks. Additionally, surgical stapling devices offer a number of advantages over sutures such as accuracy, speed, and evenness of wound closure.

According to the US Food and Drug Administration (FDA), surgical staplers have been on the market for years now and these complex mechanical medical devices have been maturing in their technology. Employed in gynecologic, gastrointestinal, thoracic, and several other surgeries, surgical stapling devices are used to cut through tissues and organs, to remove part of an organ, and to develop connections between structures.


Two major types of surgical stapling devices are available in the market: manual and powered. These devices can be either reusable or disposable. Either way, both types are loaded with disposable cartridges. Geographically, the global surgical stapling devices market covers four main segments: Asia Pacific, North America, Europe, and Rest of the World.

This report offers readers a comprehensive and objective assessment of the global surgical stapling devices market and serves as an ideal blueprint for those looking to expand or enter into a business in this avenue. Supported with accurate facts and figures pertaining to the historical, current, and future performance of the surgical stapling devices market, the report offers actionable insights into where the market is headed and the key factors driving and hampering its growth. The most prominent players competing in the space are also highlighted and reviewed based on recent developments, product portfolio, business strategies, and financial standing.

Global Surgical Stapling Devices Market: Key Trends and Opportunities

The global surgical stapling devices market is single-handedly propelled by the rise in the number of surgeries performed around the world. The demographic trend of increasing geriatric population, growing prevalence of chronic diseases, presence of favorable reimbursement scenarios in developed and developing countries, and advancing medical tourism industry have contributed toward the increase in cardiovascular, neurological, and orthopedic surgeries, among others. This growth in surgical procedures has boosted the demand for surgical stapling devices significantly. Advent of new technologies, highly developed health care infrastructure in developed countries, rising demand for powered surgical instruments and accessories in emerging economies, and growing accessibility to health care facilities in developing countries are the other factors contributing to the expansion of this market.

Global Surgical Stapling Devices Market: Region-wise Outlook

Europe and North America are the dominant regional markets for surgical stapling devices and are likely to retain their lead during the forecast period. These regions are primarily driven by the early acceptance of advanced product innovations and technically advanced equipment. Asia Pacific is a much smaller market compared to the aforementioned developed markets; however, the potential for growth in the region is exceptional.

The RoW segment of the global market also holds immense scope for growth. The patient pool in Asia Pacific and RoW is high, thus translating into an increased number of surgical procedures and soaring demand for surgical stapling devices. Rising awareness about the availability and use of advanced surgical equipment and increasing health care expenditure in several developing countries are also likely to boost the surgical stapling devices market in Asia Pacific and RoW.

Conmed Corporation, Alcon Laboratories Inc., KLS Martin Group, Zimmer Holdings Inc., Stryker Corporation, Ethicon Inc., Smith & Nephew PLC, Medtronic Inc., and CareFusion Corporation are some of the leading players operating in the global surgical stapling devices market.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11384

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Global Combined Angiography Market Analysis, Trends and Forecast by 2016 - 2024

Angiography is an X-ray imaging technique in which, contrasting agents are injected into the blood stream to visualize the blood vessels and help understand the abnormalities of blood vessels such as aneurysms and atherosclerosis. It is commonly used for diagnosing the heart diseases such as Coronary artery diseases. According to WHO, in 2012, 17.2 million people have died from cardiovascular diseases globally. Among them, 42.2% of the population were victims of the coronary artery disease. Computed Tomography (CT), angiography, and Magnetic Resonance Imaging (MRI) angiography are new angiography techniques that are used to diagnose abnormalities in blood vessels. These procedures are heal comparatively faster than conventional X-ray angiography technique (digital subtraction angiography). However, in this procedure, only abnormalities in blood vessels are diagnosed whereas conventional angiography helps in diagnosing abnormalities and treating blocked arteries.


Hence, in recent years angiographic imaging system vendors have developed combined angiography device systems, which have both DSA and CT scan to treat and diagnose the blood vessel abnormalities. These devices are present in two different operating rooms to diagnose and treat the blood vessel diseases due to which, most of the time is often lost in transferring the patients from the CT room (Diagnosis) to angio room (Treatment). Hence, combined angiography system plays an important role in treating and diagnosing the patient in same operating room and reduces space for the equipment.

These systems have a new 3D-application which links the angiography systems with CT images previously taken during the interventional process. Hence, the systems provide exceptional imaging qualities and makes it easier for surgeons to conduct surgeries. Few companies have developed mobile platforms to enable the multidisciplinary teams perform the procedures comfortably without any obligatory access to patients. In addition to these, systems will provide precision dosing, which expose the patient to less radiation as compared with the conventional system.

These systems have multiple-utility application areas, rising incidence of cardiac diseases, adaptation to new technologies and increasing awareness about the disease are the major factors driving the growth of combined angiography market. Complex regulatory process and the high cost of these systems are limiting factors for the combined angiography system market in the forecast period.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15278

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.